InvestorsHub Logo
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

Re: DanWebzster post# 61

Saturday, 03/17/2018 10:16:44 AM

Saturday, March 17, 2018 10:16:44 AM

Post# of 438
BLCM will be re-set when the BPX 501 clinical hold is resolved

BPX 501 protocol changes have already been submitted to the FDA: http://ir.bellicum.com/news-releases/news-release-details/bellicum-pharmaceuticals-provides-operational-update-and-3

Curiously, no BPX 501-related encephalopathy have been reported in the European registration study.

Reported positive interim Ph2 open label data in pediatric patients with acute AML & primary immunodeficiency 3/18.

Cash runway can be stretced thru Q1,2019

I speculate that dilution will occur not long after the lifting of the clinical hold.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.